Kobuchi S

References (3)

Title : Identification of daurioxoisoporphine D and moringamine I as blood-brain barrier-permeable natural inhibitors of amyloid-beta aggregation and neuronal toxicity - Yoshikawa_2026_Bioorg.Med.Chem_138_118664
Author(s) : Yoshikawa H , Yoshida E , Matsumoto T , Sugita K , Kamiya S , Ohgita T , Kobuchi S , Shimohama S , Takata K
Ref : Bioorganic & Medicinal Chemistry , 138 :118664 , 2026
Abstract :
PubMedSearch : Yoshikawa_2026_Bioorg.Med.Chem_138_118664
PubMedID: 42008955

Title : Assessment of drug-drug interaction and optimization in capecitabine and irinotecan combination regimen using a physiologically based pharmacokinetic model - Sakai_2021_J.Pharm.Sci__
Author(s) : Sakai S , Kobuchi S , Ito Y , Sakaeda T
Ref : J Pharm Sci , : , 2021
Abstract :
PubMedSearch : Sakai_2021_J.Pharm.Sci__
PubMedID: 34965386

Title : Assessment of pharmacokinetic variations of capecitabine after multiple administration in rats: a physiologically based pharmacokinetic model - Sakai_2020_Cancer.Chemother.Pharmacol__
Author(s) : Sakai S , Kobuchi S , Ito Y , Sakaeda T
Ref : Cancer Chemother Pharmacol , : , 2020
Abstract :
PubMedSearch : Sakai_2020_Cancer.Chemother.Pharmacol__
PubMedID: 32240335